Abstract:
This article explores the intricate relationship between neurochemistry and psychiatric disorders, highlighting recent empirical findings. We focus on key neurotransmitter systems—specifically serotonin, dopamine, and norepinephrine—and their roles in mood regulation and the pathology of mental health disorders. The review synthesizes current research on major depressive disorder and schizophrenia, examining how alterations in these neurotransmitter systems contribute to symptomatology. Recent advancements in neuroimaging and biochemical techniques, such as magnetic resonance spectroscopy (MRS) and positron emission tomography (PET), have significantly improved our understanding of neurotransmitter dynamics in the brain. These methods provide crucial insights into the biochemical processes underlying psychiatric conditions, paving the way for more targeted and effective treatment strategies. The findings emphasize the importance of a neurochemical perspective in the study of psychiatric disorders and suggest directions for future research. Understanding the complex interplay between neurochemistry and behavior can inform more personalized approaches to treatment, ultimately improving patient outcomes.